GL1X · GenesisL1 explorer

Ligand · QAM

QAM · N-(5-{[1-(5-amino-1,3,4-thiadiazol-2-yl)piperidin-4-yl]oxy}-1,3,4-thiadiazol-2-yl)-2-phenylacetamide

QAM, N-(5-{[1-(5-amino-1,3,4-thiadiazol-2-yl)piperidin-4-yl]oxy}-1,3,4-thiadiazol-2-yl)-2-phenylacetamide (C17 H19 N7 O2 S2, 417.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…

Component
QAM
Formula
C17 H19 N7 O2 S2
Class
ligand
Structures
2
PDB entries
1

Binding sites

QAM in 2 structures; the first of them:

  • 6UMF · Crystal structure of human GAC in complex with inhibitor UPGL00012 · QAM B601 · binds LYS320, LEU321, PHE322, LEU323, ASN324, TYR394, LYS320, LEU321 and 7 more
  • 6UMF · Crystal structure of human gac in complex with inhibitor UPGL00012 · QAM B601 · binds LYS320, LEU321, PHE322, LEU323, ASN324, TYR394, LYS320, LEU321 and 6 more

Residues it binds most

LEU 4, LYS 4, PHE 4, TYR 4, ASN 4, ARG 4, GLU 4, ASP 1 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.